These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 19077118

  • 1. Genetic variants in COMT and neurocognitive impairment in families of patients with schizophrenia.
    Liao SY, Lin SH, Liu CM, Hsieh MH, Hwang TJ, Liu SK, Guo SC, Hwu HG, Chen WJ.
    Genes Brain Behav; 2009 Mar; 8(2):228-37. PubMed ID: 19077118
    [Abstract] [Full Text] [Related]

  • 2. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives.
    Golimbet V, Gritsenko I, Alfimova M, Lebedeva I, Lezheiko T, Abramova L, Kaleda V, Ebstein R.
    World J Biol Psychiatry; 2006 Mar; 7(4):238-45. PubMed ID: 17071544
    [Abstract] [Full Text] [Related]

  • 3. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
    Minzenberg MJ, Xu K, Mitropoulou V, Harvey PD, Finch T, Flory JD, New AS, Goldman D, Siever LJ.
    Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
    [Abstract] [Full Text] [Related]

  • 4. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK.
    Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583
    [Abstract] [Full Text] [Related]

  • 5. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
    Neuhaus AH, Opgen-Rhein C, Urbanek C, Hahn E, Ta TM, Seidelsohn M, Strathmann S, Kley F, Wieseke N, Sander T, Dettling M.
    Pharmacopsychiatry; 2009 Jul; 42(4):141-4. PubMed ID: 19585392
    [Abstract] [Full Text] [Related]

  • 6. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET).
    Rybakowski JK, Borkowska A, Czerski PM, Dmitrzak-Weglarz M, Skibinska M, Kapelski P, Hauser J.
    Psychiatry Res; 2006 Jun 30; 143(1):13-9. PubMed ID: 16712949
    [Abstract] [Full Text] [Related]

  • 7. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR.
    Arch Gen Psychiatry; 2003 Sep 30; 60(9):889-96. PubMed ID: 12963670
    [Abstract] [Full Text] [Related]

  • 8. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.
    Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS.
    Mol Psychiatry; 2004 Oct 30; 9(10):962-7. PubMed ID: 15124004
    [Abstract] [Full Text] [Related]

  • 9. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population.
    Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T.
    Neurosci Res; 2007 Jul 30; 58(3):291-6. PubMed ID: 17482701
    [Abstract] [Full Text] [Related]

  • 10. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, Czerski PM, Hauser J.
    Psychiatry Clin Neurosci; 2006 Feb 30; 60(1):70-6. PubMed ID: 16472361
    [Abstract] [Full Text] [Related]

  • 11. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M, Bechi M, Marino E, Anselmetti S, Poletti S, Cocchi F, Smeraldi E, Cavallaro R.
    Neurosci Lett; 2007 May 07; 417(3):271-4. PubMed ID: 17383818
    [Abstract] [Full Text] [Related]

  • 12. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P, Ortuño F, Zalacain M, Patiño-García A.
    Pharmacogenomics J; 2007 Dec 07; 7(6):418-26. PubMed ID: 17363961
    [Abstract] [Full Text] [Related]

  • 13. COMT val158Met and executive control: a test of the benefit of specific deficits to translational research.
    MacDonald AW, Carter CS, Flory JD, Ferrell RE, Manuck SB.
    J Abnorm Psychol; 2007 May 07; 116(2):306-12. PubMed ID: 17516763
    [Abstract] [Full Text] [Related]

  • 14. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA, Devlin B, Pollock BG, Sukonick DL, Kastango KB, Bacanu SA, Chowdari KV, DeKosky ST, Ferrell RE.
    Mol Psychiatry; 2005 Nov 07; 10(11):1026-36. PubMed ID: 16027741
    [Abstract] [Full Text] [Related]

  • 15. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Leister F, Krivogorsky B, Yolken RH.
    Bipolar Disord; 2006 Apr 07; 8(2):124-32. PubMed ID: 16542182
    [Abstract] [Full Text] [Related]

  • 16. Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
    Lopez-Garcia P, Young Espinoza L, Molero Santos P, Marin J, Ortuño Sanchez-Pedreño F.
    Psychiatry Res; 2013 Jul 30; 208(2):118-24. PubMed ID: 23102922
    [Abstract] [Full Text] [Related]

  • 17. Effects of brain-derived neurotrophic factor-catecholamine-O-methyltransferase gene interaction on schizophrenic symptoms.
    Han DH, Park DB, Choi TY, Joo SY, Lee MK, Park BR, Nishimura R, Chu CC, Renshaw PF.
    Neuroreport; 2008 Jul 16; 19(11):1155-8. PubMed ID: 18596619
    [Abstract] [Full Text] [Related]

  • 18. COMT haplotypes suggest P2 promoter region relevance for schizophrenia.
    Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A, Okonofua F, Kajuna S, Karoma N, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu RB, Parnas J, Kidd JR, DeMille MM, Kidd KK.
    Mol Psychiatry; 2004 Sep 16; 9(9):859-70. PubMed ID: 15098000
    [Abstract] [Full Text] [Related]

  • 19. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations.
    Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, Gilliam TC.
    Biol Psychiatry; 2005 Dec 01; 58(11):901-7. PubMed ID: 16043133
    [Abstract] [Full Text] [Related]

  • 20. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients.
    Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG.
    Am J Psychiatry; 1998 Sep 01; 155(9):1214-20. PubMed ID: 9734545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.